S
MBX

SignatureFD’s MBX Biosciences MBX Stock Holding History

SignatureFD’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.31K Sell
78
-101
-56% -$3.53K ﹤0.01% 2903
2026
Q1 		$5.34K Hold
179
– – ﹤0.01% 2756
2025
Q4 		$5.65K Hold
179
– – ﹤0.01% 2648
2025
Q3 		$3.13K Buy
179
+78
+77% +$1.04K ﹤0.01% 2817
2025
Q2 		$1.15K Buy
+101
New +$1.03K ﹤0.01% 2991

Other funds holding MBX

AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
KWM
Koa Wealth Management Encinitas, California $147M AUM 18.41% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
PWA
Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return

SignatureFD's MBX Position: Q2 2026 in Review

SignatureFD reduced its MBX Biosciences (MBX) stake by 56% in Q2 2026, selling an estimated $3.53K and leaving 78 shares worth $4.31K. The position accounts for ﹤0.01% of the portfolio, ranked #2903.

SignatureFD first reported a position in MBX in Q2 2025 and has held it in 5 quarters since. The position peaked at $5.65K in Q4 2025. 16 funds tracked by Wall St. Rank hold MBX as of Q2 2026.

  • SignatureFD held 78 shares of MBX Biosciences worth $4.31K as of Q2 2026.
  • SignatureFD sold 101 MBX Biosciences shares in Q2 2026, an estimated $3.53K.
  • MBX Biosciences made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2903 holding.
  • SignatureFD first reported a position in MBX Biosciences in Q2 2025 and has held it in 5 quarters since.
  • SignatureFD's MBX Biosciences position peaked at $5.65K in Q4 2025.
  • 16 funds tracked by Wall St. Rank held MBX Biosciences as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.